Evidence map›Paper›PMID 33322236›Full record

ArticleMicroorganisms2020

Post-Vaccination

Richael O Mills, Mohammed R Abdullah, Samuel A Akwetey, Dorcas C Sappor, Isaac Cole, Michael Baffuor-Asare, Johan A Bolivar, Gustavo Gámez, Mark P G van der Linden, Sven Hammerschmidt

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Richael O MillsDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, 17487 Greifswald, Germany.ORCID 0000-0003-1596-8543
Mohammed R AbdullahDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, 17487 Greifswald, Germany.
Samuel A AkweteyDepartment of Biomedical sciences, University of Cape Coast, Cape Coast, Ghana.
Dorcas C SapporDepartment of Biomedical sciences, University of Cape Coast, Cape Coast, Ghana.
Isaac ColeDepartment of Microbiology, Central Laboratory Service, Korle Bu Teaching Hospital, Accra 00233, Ghana.
Michael Baffuor-AsareDepartment of Microbiology, Central Laboratory Service, Korle Bu Teaching Hospital, Accra 00233, Ghana.
Johan A BolivarBasic and Applied Microbiology (MICROBA) School of Microbiology, University of Antioquia Medellin, 050010 Medellin, Colombia.
Gustavo GámezBasic and Applied Microbiology (MICROBA) School of Microbiology, University of Antioquia Medellin, 050010 Medellin, Colombia.ORCID 0000-0002-5957-9163
Mark P G van der LindenGerman National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Sven HammerschmidtDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, 17487 Greifswald, Germany.ORCID 0000-0002-6382-6681
University of Cape Coast · GHKorle Bu Teaching Hospital · GHUniversidad de Antioquia · COUniversität Greifswald · DERWTH Aachen University · DE

Funding

Bundesministerium für Bildung und Forschung Zwanzig20 -InfectControl 2020 - Project VacoME - FKZ 03ZZ0816ADeutscher Akademischer Austauschdienst 57251550
6 · The paper itself

Abstract

In 2012, Ghana introduced PCV13 into its childhood immunization program. To monitor the pneumococcus after PCV13 vaccination, we analyzed serotypes, antibiotic resistance, and virulence genes of pneumococcal carriage isolates among children under five years of age. We obtained nasopharyngeal swabs from 513 children from kindergartens and immunization centers in Cape Coast, Ghana. Pneumococcal serotypes were determined by multiplex-PCR and Quellung reaction. Antibiotic resistance and virulence genes prevalence were determined by disc diffusion and PCR respectively. Overall, carriage prevalence was 29.4% and PCV13 coverage was 38.4%. Over 60% of the isolates were non-PCV13 serotypes and serotype 23B was the most prevalent. One isolate showed full resistance to penicillin, while 35% showed intermediate resistance. Resistance to erythromycin and clindamycin remained low, while susceptibility to ceftriaxone, levofloxacin and vancomycin remained high. Penicillin resistance was associated with PCV13 serotypes. Forty-three (28.5%) strains were multidrug-resistant. Virulence genes

Indexed as

antibiotic resistanceGhanaPCV13pneumococcal carriageserotypesvirulence genes

Identifiers

PMID33322236
PMCPMC7764876
OpenAlexW3111464176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.